US pension fund LACERA to commit $100m to Chinese biomedical VC firm LAV

US pension fund LACERA to commit $100m to Chinese biomedical VC firm LAV

Laboratory equipment. Photo: Pixabay

22 January, 2021

biomedical LACERA LAV Fund VI LAV Fund VI Opportunities Lilly Asia Ventures

Printed by Unregistered user on Fri, 25 Jul 2025 13:19:10 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Chinese drug maker SciNeuro Pharma raises $100m co-led by LAV, Arch Venture Partners

US pension LACERA commits $130m to GGV Capital’s three new funds

Read more from Greater China

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure

Hong Kong-based crypto platform OSL Group raises $300m equity funding